ProCE Banner Events

Share

Transforming Frontline Therapy in Hodgkin Lymphoma: Advancing Personalized Strategies for Optimal Outcomes

Join us in person or virtually for this CME-certified, live satellite symposium at ASCO 2025 on the landscape of frontline treatment for Hodgkin lymphoma in adult, pediatric, and adolescent and young adult patients. Gain expert insights into the latest treatment options, individualizing therapy, and proactively managing adverse events.

Not an official event of the 2025 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation.

Physicians: maximum of 1.50 AMA PRA Category 1 Credits™

Physicians ABIM MOC: maximum of 1.50 Medical Knowledge MOC points

Who Should Attend

This educational activity is intended for hematologists, oncologists, and other healthcare professionals who care for patients with Hodgkin lymphoma. 

Time and location

Saturday, May 31, 2025

6:30 PM - 8:30 PM Central Time (CT)

In-person

7:00 PM - 8:30 PM Central Time (CT)

Virtual

Hilton Chicago
720 S Michigan Ave
Chicago, Illinois 60605

Salon A4

Agenda

Registration & Dinner: 6:30 PM - 7:00 PM CT
Symposium: 7:00 PM - 8:30 PM CT

The Landscape of Frontline Treatment Options in Hodgkin lymphoma (HL)

Practical Considerations for the Community HCP in the Application of Frontline Treatment of HL

Special Considerations for Older Patients with HL

Special Considerations for Pediatric and AYA Patients with HL

On The Horizon: Novel Agents and Combination Therapy

Location

Venue Name

Hilton Chicago

Address

Hilton Chicago
720 S Michigan Ave
Chicago, Illinois 60605

Room Name

Salon A4

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of learners to optimize care of patients with Hodgkin lymphoma.

Target Audience
This educational activity is intended for hematologists, oncologists, and other healthcare professionals who care for patients with Hodgkin lymphoma. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Analyze the criteria for accurate lymphoma subclassification and the impact of prognostic biomarkers, emphasizing the importance of early intervention

  • Plan individualized frontline treatment strategies for patients with Hodgkin lymphoma, considering available clinical data, expert recommendations, and patient preferences

  • Apply new treatment options to improve frontline therapy for special populations such as older, pediatric, and AYA patients with HL, considering patient-related factors and risk stratification

  • Devise proactive measures for identifying, monitoring, and addressing treatment-related adverse events associated with modern frontline therapy approaches, especially in older and pediatric patients with HL

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/67167f3d10da3.png

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporter

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.